{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:11:17Z","timestamp":1788487877976,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jns.2024.123201","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T15:47:00Z","timestamp":1725032820000},"page":"123201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tissue plasminogen activator for acute branch atheromatous disease exhibits transient improvement and worsening"],"prefix":"10.1016","volume":"465","author":[{"given":"Yuya","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Kuasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-ichi","family":"Tazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2024.123201_bb0005","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/STROKEAHA.118.021840","article-title":"Rapid Alteplase administration improves functional outcomes in patients with stroke due to large vessel occlusions","volume":"50","author":"Goyal","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123201_bb0010","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","author":"Group. TNIoNDaSr-PSS","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2024.123201_bb0015","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.39.9.1246","article-title":"Intracranial branch atheromatous disease: a neglected, understudied, and underused concept","volume":"39","author":"Caplan","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123201_bb0020","first-page":"900","article-title":"Basilar artery branch occlusion. A cause of pontine infarction","volume":"21","author":"Fisher","year":"1971"},{"key":"10.1016\/j.jns.2024.123201_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000144084","article-title":"Neurological and MRI findings as predictors of progressive-type lacunar infarction","volume":"60","author":"Nagakane","year":"2008","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2024.123201_bb0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jns.2011.02.006","article-title":"Characteristics of intracranial branch atheromatous disease and its association with progressive motor deficits","volume":"304","author":"Yamamoto","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123201_bb0035","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.STR.21.4.637","volume":"21","year":"1990","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123201_bb0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123201_bb0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ca.1032","article-title":"Anatomic and clinical correlations of the lenticulostriate arteries","volume":"14","author":"Marinkovi\u0107","year":"2001","journal-title":"Clin. Anatom.: Off. J. American Assoc. Clin. Anatom. British Assoc. Clin. Anatomist."},{"key":"10.1016\/j.jns.2024.123201_bb0050","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.10.005","article-title":"Clinical evaluation of lacunar infarction and branch atheromatous disease","volume":"22","author":"Nakase","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2024.123201_bb0055","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/STROKEAHA.114.005757","article-title":"Thrombolysis in ischemic stroke without arterial occlusion at presentation","volume":"45","author":"Lahoti","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2024.123201_bb0060","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jns.2017.08.3181","article-title":"Intravenous thrombolysis in lacunar stroke","volume":"381","author":"Zivanovic","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2024.123201_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000091982","article-title":"Does thrombolysis benefit patients with lacunar syndrome?","volume":"55","author":"Cocho","year":"2006","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jns.2024.123201_bb0070","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00415-013-7212-8","article-title":"Thrombolysis in patients with lacunar stroke is safe: an observational study","volume":"261","author":"Griebe","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2024.123201_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jocn.2016.04.011","article-title":"Intravenous tissue plasminogen activator in acute branch atheromatous disease: does it prevent early neurological deterioration?","volume":"33","author":"Park","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2024.123201_bb0080","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2024.123201_bb0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge","volume":"76","author":"Chesebro","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2024.123201_bb0090","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jemermed.2023.03.059","article-title":"A 5-minute delay from bolus injection to infusion halves plasma concentration of tissue plasminogen activator","volume":"64","author":"Kobayashi","year":"2023","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.jns.2024.123201_bb0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/01.CIR.73.2.347","article-title":"Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion","volume":"73","author":"Gold","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jns.2024.123201_bb0100","first-page":"204","article-title":"Formation, inhibition and clearance of plasmin in vivo","volume":"30","author":"Chandler","year":"2000","journal-title":"Haemostasis"},{"key":"10.1016\/j.jns.2024.123201_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1011952602122","article-title":"Plasminogen activator inhibitor type-1 (part two): role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents","volume":"11","author":"Huber","year":"2001","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.jns.2024.123201_bb0110","series-title":"Plasminogen Activator Inhibitor-1: The Expression, Biological Functions, and Effects on Tumorigenesis and Tumor Cell Adhesion and Migration","volume":"1","author":"Lee","year":"2004"},{"key":"10.1016\/j.jns.2024.123201_bb0115","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1161\/01.CIR.99.23.3050","article-title":"Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance","volume":"99","author":"Zhu","year":"1999","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1016\/j.jns.2024.123241","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000}}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24003368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T02:32:29Z","timestamp":1726021949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24003368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":23,"alternative-id":["S0022510X24003368"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123201","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jns.2024.123241","asserted-by":"object"}]},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue plasminogen activator for acute branch atheromatous disease exhibits transient improvement and worsening","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123201","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123201"}}